Vr Adviser, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
A detailed history of Vr Adviser, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 677,600 shares of FDMT stock, worth $2.22 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
677,600
Previous 2,952,371
77.05%
Holding current value
$2.22 Million
Previous $16.4 Million
86.69%
% of portfolio
0.53%
Previous 2.71%
Shares
5 transactions
Others Institutions Holding FDMT
# of Institutions
130Shares Held
46.8MCall Options Held
25.8KPut Options Held
33.4K-
Black Rock Inc. New York, NY4.9MShares$16 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA4.56MShares$14.9 Million0.31% of portfolio
-
Bvf Inc San Francisco, CA4.56MShares$14.9 Million0.65% of portfolio
-
Goldman Sachs Group Inc New York, NY4.17MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.76MShares$9.02 Million0.0% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $106M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...